These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20638758)

  • 21. Factor V Inhibitors: A Diagnostic and Therapeutic Challenge.
    Olson NJ; Ornstein DL
    Arch Pathol Lab Med; 2017 Dec; 141(12):1728-1731. PubMed ID: 29189062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of antibodies to human thrombin and factor V in a pediatric patient exposed to topical bovine thrombin.
    Lo CY; Jones C; Glader B; Zehnder JL
    Pediatr Blood Cancer; 2010 Dec; 55(6):1195-7. PubMed ID: 20979176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parahemophilia: new insights into factor v deficiency.
    Thalji N; Camire RM
    Semin Thromb Hemost; 2013 Sep; 39(6):607-12. PubMed ID: 23893775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spectrum of bleeding in acquired factor V inhibitor: a summary of 33 cases.
    Wiwanitkit V
    Clin Appl Thromb Hemost; 2006 Oct; 12(4):485-8. PubMed ID: 17000894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acquired Factor V Deficiency Associated with CFPM Administration.
    Yamanishi M; Nishimi Y; Usui M; Miki K; Imashuku S
    Clin Lab; 2019 Oct; 65(10):. PubMed ID: 31625361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma Exchange as an Initial Treatment for Severe Bleeding Induced by Acquired Factor V Deficiency: A Case Report and Mini Literature Review.
    Yanagiya R; Kanouchi K; Toubai T; Yamada A; Aizawa K; Shiono Y; Ito S; Ishizawa K
    Acta Haematol; 2021; 144(1):82-87. PubMed ID: 32784304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acquired factor V inhibitor. A problem-based systematic review.
    Ang AL; Kuperan P; Ng CH; Ng HJ
    Thromb Haemost; 2009 May; 101(5):852-9. PubMed ID: 19404538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastric bypass in a factor V deficient patient.
    Husain S; Ballem N; Beaton HL
    Obes Surg; 2006 Aug; 16(8):1104-6. PubMed ID: 16901369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hereditary factor V deficiency and factor V inhibitor without bleeding. Rare causes of pathological screening tests of coagulation].
    Borucki K; Töpfer G; Hartung KJ; Lutze G
    Hamostaseologie; 2007 Aug; 27(3):188-90. PubMed ID: 17694226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A neonatal presentation of factor V deficiency: a case report.
    Chingale A; Eisenhut M; Gadiraju A; Liesner R
    BMC Pediatr; 2007 Feb; 7():8. PubMed ID: 17313676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in understanding the bleeding diathesis in factor V deficiency.
    Duckers C; Simioni P; Rosing J; Castoldi E
    Br J Haematol; 2009 Jun; 146(1):17-26. PubMed ID: 19438479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Development of asymptomatic acquired factor V inhibitor after the administration of antibiotics].
    Kinjo Y; Yoshimura K; Suzuki T; Shinozawa K; Nakasone K; Yoshimata T; Nishihira M; Henzan E
    Rinsho Ketsueki; 2014 Nov; 55(11):2311-5. PubMed ID: 25501413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure.
    Streiff MB; Ness PM
    Transfusion; 2002 Jan; 42(1):18-26. PubMed ID: 11896308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acquired factor V inhibitor: a nation-wide study of 38 patients.
    Goulenok T; Vasco C; Faille D; Ajzenberg N; De Raucourt E; Dupont A; Frere C; James C; Rabut E; Rugeri L; Schleinitz N; Sacré K; Papo T;
    Br J Haematol; 2021 Mar; 192(5):892-899. PubMed ID: 33471937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transient Factor V deficiency associated with Factor V-immunoglobulin complexes but without evidence of a classical inhibitor.
    Cortier D; Van Dreden P; Adam M; Bironien R; François D; Vasse M
    Thromb Res; 2016 Nov; 147():10-12. PubMed ID: 27664390
    [No Abstract]   [Full Text] [Related]  

  • 36. [Menorrhagia due to congenital factor V deficiency in an adolescent].
    Chemaou A; Ayachi M; Benjelloun O; Zineddine A
    Arch Pediatr; 2013 Jan; 20(1):33-6. PubMed ID: 23182898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acquired factor V inhibitor in a critically ill patient.
    Morris CJ; Curry N
    Anaesthesia; 2009 Sep; 64(9):1014-7. PubMed ID: 19686488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acquired factor V inhibitor developing in a patient with esophageal squamous cell carcinoma.
    Ahmadinejad M; Roushan N
    Blood Coagul Fibrinolysis; 2013 Jan; 24(1):97-9. PubMed ID: 23080366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rectal bleeding after hypofractionated radiotherapy for prostate cancer: correlation between clinical and dosimetric parameters and the incidence of grade 2 or worse rectal bleeding.
    Akimoto T; Muramatsu H; Takahashi M; Saito J; Kitamoto Y; Harashima K; Miyazawa Y; Yamada M; Ito K; Kurokawa K; Yamanaka H; Nakano T; Mitsuhashi N; Niibe H
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1033-9. PubMed ID: 15519772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid elimination of a high-titer spontaneous factor V antibody by extracorporeal antibody-based immunoadsorption and immunosuppression.
    Tribl B; Knöbl P; Derfler K; Kapiotis S; Aspöck G; Jäger U; Hörl W; Lechner K
    Ann Hematol; 1995 Oct; 71(4):199-203. PubMed ID: 7578528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.